Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China
· Delayed Price · Currency is CNY 19.80
+0.26 (1.33%)
Mar 10, 2026, 11:29 AM CST
Cabio Biotech (Wuhan) Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 574.88 | 542.29 | 435.39 | 402.08 | 350.76 | Upgrade
|
| Other Revenue | - | 13.31 | 8.41 | 31.35 | 0.35 | Upgrade
|
| Revenue | 574.88 | 555.59 | 443.8 | 433.42 | 351.11 | Upgrade
|
| Revenue Growth (YoY) | 3.47% | 25.19% | 2.40% | 23.44% | 8.55% | Upgrade
|
| Cost of Revenue | - | 326.81 | 264.51 | 257.14 | 172.33 | Upgrade
|
| Gross Profit | 574.88 | 228.78 | 179.29 | 176.29 | 178.78 | Upgrade
|
| Selling, General & Admin | - | 72.35 | 56.34 | 64.32 | 42.18 | Upgrade
|
| Research & Development | - | 47.57 | 38.23 | 31.84 | 30.54 | Upgrade
|
| Other Operating Expenses | 409.91 | 5.36 | 6.38 | 4.56 | 5.01 | Upgrade
|
| Operating Expenses | 409.91 | 125.82 | 103.21 | 111.93 | 77.08 | Upgrade
|
| Operating Income | 164.97 | 102.97 | 76.08 | 64.35 | 101.7 | Upgrade
|
| Interest Expense | - | -0.4 | -0.6 | -0.37 | -0.35 | Upgrade
|
| Interest & Investment Income | - | 3.52 | 7.41 | 7.12 | 16.83 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 2.78 | 1.08 | 11.28 | -2.6 | Upgrade
|
| Other Non Operating Income (Expenses) | 13.99 | -2.31 | 26.37 | 23.94 | 34.41 | Upgrade
|
| EBT Excluding Unusual Items | 178.96 | 106.56 | 110.34 | 106.33 | 149.99 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 0.27 | -2.64 | -37.8 | 0.99 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0 | 0.05 | 0 | -2.4 | Upgrade
|
| Asset Writedown | - | -5.21 | -4.13 | -0.69 | - | Upgrade
|
| Other Unusual Items | - | 38.21 | -3.62 | 10.29 | 3.48 | Upgrade
|
| Pretax Income | 178.96 | 139.82 | 100 | 78.14 | 152.06 | Upgrade
|
| Income Tax Expense | 22.26 | 19.69 | 13.63 | 16.56 | 20.77 | Upgrade
|
| Earnings From Continuing Operations | 156.7 | 120.13 | 86.37 | 61.58 | 131.29 | Upgrade
|
| Minority Interest in Earnings | - | 4.08 | 5.01 | 2.79 | -2.72 | Upgrade
|
| Net Income | 156.7 | 124.21 | 91.37 | 64.37 | 128.58 | Upgrade
|
| Net Income to Common | 156.7 | 124.21 | 91.37 | 64.37 | 128.58 | Upgrade
|
| Net Income Growth | 26.15% | 35.94% | 41.95% | -49.94% | -1.54% | Upgrade
|
| Shares Outstanding (Basic) | 167 | 168 | 169 | 169 | 168 | Upgrade
|
| Shares Outstanding (Diluted) | 167 | 168 | 169 | 169 | 168 | Upgrade
|
| Shares Change (YoY) | -0.69% | -0.80% | -0.11% | 0.69% | 0.31% | Upgrade
|
| EPS (Basic) | 0.94 | 0.74 | 0.54 | 0.38 | 0.76 | Upgrade
|
| EPS (Diluted) | 0.94 | 0.74 | 0.54 | 0.38 | 0.76 | Upgrade
|
| EPS Growth | 27.03% | 37.04% | 42.10% | -50.28% | -1.84% | Upgrade
|
| Free Cash Flow | - | -38.55 | -228.79 | -73.07 | -70.14 | Upgrade
|
| Free Cash Flow Per Share | - | -0.23 | -1.35 | -0.43 | -0.42 | Upgrade
|
| Dividend Per Share | - | 0.201 | 0.200 | 0.214 | 0.236 | Upgrade
|
| Dividend Growth | - | 0.47% | -6.67% | -9.08% | - | Upgrade
|
| Gross Margin | 100.00% | 41.18% | 40.40% | 40.67% | 50.92% | Upgrade
|
| Operating Margin | 28.70% | 18.53% | 17.14% | 14.85% | 28.97% | Upgrade
|
| Profit Margin | 27.26% | 22.36% | 20.59% | 14.85% | 36.62% | Upgrade
|
| Free Cash Flow Margin | - | -6.94% | -51.55% | -16.86% | -19.98% | Upgrade
|
| EBITDA | 219.23 | 157.22 | 123.14 | 90.4 | 125.02 | Upgrade
|
| EBITDA Margin | 38.13% | 28.30% | 27.74% | 20.86% | 35.61% | Upgrade
|
| D&A For EBITDA | 54.25 | 54.25 | 47.06 | 26.04 | 23.32 | Upgrade
|
| EBIT | 164.97 | 102.97 | 76.08 | 64.35 | 101.7 | Upgrade
|
| EBIT Margin | 28.70% | 18.53% | 17.14% | 14.85% | 28.97% | Upgrade
|
| Effective Tax Rate | 12.44% | 14.08% | 13.63% | 21.19% | 13.66% | Upgrade
|
| Revenue as Reported | - | 555.59 | 443.8 | 433.42 | 351.11 | Upgrade
|
| Advertising Expenses | - | 6.61 | 5.28 | 2.27 | 1.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.